(MENAFNEditorial)
ResearchMoz.us include new market research report"Global Diabetic Retinopathy Market 2015-2019 " to its huge collection of research reports.
About Diabetic Retinopathy
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
Full Report With TOC @ http://www.researchmoz.us/global-diabetic-retinopathy-market-2015-2019-report.html
Laser surgery injection of corticosteroids or anti-VEGF drugs into the eye and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute delicate and previously injured blood vessels located at the back of the eye which then collects in the macula. This results in inflammation of tissue and blurry vision.
Technavio's analysts forecast the global diabetic retinopathy market to grow at a CAGR of 6.89% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global diabetic retinopathy market for the period 2015-2019. To calculate the market size the report considers revenue from the sales of prescribed as well as off-label drugs available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the four major vendors in the market. In addition it discusses the major drivers that influence the growth and the challenges faced by the vendors and the market at large as well as the key trends that contribute to the growth the market.
Technavio's report Global Diabetic Retinopathy Market 2015-2019 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas EMEA and APAC; it also covers the global diabetic retinopathy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
APAC
EMEA
Key Vendors
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html
Other Prominent Vendors
Actavis
Alimera Sciences
Ampio Pharmaceuticals
Antisense Therapeutics
BCN Peptides
Boehringer Ingelheim
Glycadia
iCo Therapeutics
Isis Pharmaceuticals
Kowa Group
Lpath
Numoda Capital
Ohr Pharmaceutical
OPKO Health
Parexel International
Promedior
pSivida
Quark Pharmaceuticals
R-Tech Ueno
Sirnaomics
ThromboGenics
Market Driver
Growth in patient population
For a full detailed list view our report
Market Challenge
Availability of effective surgical treatments
For a full detailed list view our report
Market Trend
Launch of novel agents
For a full detailed list view our report
All Technavio Market Research Reports @ http://www.researchmoz.us/publisher/technavio-73.html
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite:http://www.researchmoz.us/
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.